← ANALYST RATINGS · TIPRANKS
Solventum Corporation (SOLV): analyst forecast and price target
Analyst consensus
Hold0 Buy1 Hold0 Sell
Ratings of 1 analysts in the last 3 months · top analysts only12-month forecast
Based on 1 price targets given in the last 3 months, the average target is $95.00, the highest $95.00, the lowest $95.00. The average is +10.7% from the last price of $85.81.
Analyst ratings 14
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $95.00 | Buy | +10.7% | Reiterated | 09.10.26on TipRanks Oct 12 09:45 | +0.4%next day −2.2% · 5 days +0.3% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $95.00 | Hold | +10.7% | Reiterated | 09.10.26on TipRanks Oct 11 19:15 | +0.4%next day −2.2% · 5 days +0.3% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $100 | Buy | +16.5% | Reiterated | 18.09.26on TipRanks 07:10 | +1.4%next day −1.6% · 5 days −0.5% | ↗ |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $105 | Buy | +22.4% | Reiterated | 15.09.26on TipRanks 07:30 | +0.7%next day −0.9% · 5 days −3.8% | ↗ |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $93.00 → $103+10.8% | Buy | +20.0% | Reiterated | 07.09.26on TipRanks 11:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $91.00 → $100+9.9% | Hold | +16.5% | Reiterated | 07.09.26on TipRanks 11:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $90.00 → $99.00+10.0% | Hold | +15.4% | Downgrade | 07.09.26on TipRanks 11:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $85.00 → $94.00+10.6% | Hold | +9.5% | Reiterated | 07.09.26on TipRanks 11:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $95.00 → $105+10.5% | Buy | +22.4% | Reiterated | 07.09.26on TipRanks 11:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $90.00 → $99.00+10.0% | Hold | +15.4% | Downgrade | 07.09.26on TipRanks 11:05 | — | |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $101 | Buy | +17.7% | Assigned | 20.08.26on TipRanks 07:35 | +1.8%next day +0.7% · 5 days +1.5% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $84.00 | Hold | −2.1% | Reiterated | 17.08.26on TipRanks 07:41 | −1.5%next day +1.4% · 5 days +6.3% | ↗ |
| Nathan Treybeck★★★★★★★★★★#10843 · hits 28% · avg −5.3% | Wells Fargo | $70.00 → $89.00+27.1% | Hold | +3.7% | Reiterated | 06.08.26on TipRanks 14:25 | −5.0%next day −0.6% · 5 days +3.0% | ↗ |
| Michael Piccolo★★★★★★★★★★#9828 · hits 44% · avg −2.5% | Wedbush | $94.00 → $101+7.4% | Buy | +17.7% | Reiterated | 06.08.26on TipRanks 08:50 | −5.0%next day −0.6% · 5 days +3.0% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $100 → $113+13.0% | Buy | +31.7% | Reiterated | 06.08.26on TipRanks 07:31 | −5.0%next day −0.6% · 5 days +3.0% | ↗ |
| Brett Fishbin★★★★★★★★★★#10514 · hits 45% · avg −3.0% | KeyBanc | $93.00 → $102+9.7% | Buy | +18.9% | Reiterated | 06.08.26on TipRanks 04:16 | −5.0%next day −0.6% · 5 days +3.0% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $66.00 | Sell | −23.1% | Reiterated | 05.05.26on TipRanks May 6 09:06 | +1.6%next day +1.4% · 5 days +6.8% | ↗ |
| Mark Strouse★★★★★★★★★★#2081 · hits 47% · avg +6.2% | J.P. Morgan | — | Buy | — | Initiated | 06.04.26on TipRanks Apr 8 08:35 | −1.0%next day −1.2% · 5 days +2.5% | ↗ |
| Unknown Analyst | Rothschild & Co Redburn | $60.00 | Sell | −30.1% | Initiated | 24.03.26on TipRanks 11:05 | −2.2%next day +0.4% · 5 days +2.4% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | — | Buy | — | Reiterated | 12.12.25on TipRanks Dec 14 03:35 | +1.3%next day −1.2% · 5 days −1.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Solventum Corporation
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $98.50 at a price of $88.15 (+11.7%); now: $98.50 at $85.81 (+14.8%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 5 | 3 | 3 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.35 (from $1.29 to $1.43). Last quarter: $2.55.
Sales
Next quarter’s sales estimate — $1.9B (from $1.9B to $2.0B). Last quarter: $2.2B.
Best top-analyst consensus in the sector · Healthcare
About Solventum Corporation
- CEO: Bryan C. Hanson
- Employees: 20,584
- 1750 Yankee Doodle Road, Eagan, MN, 55121, US
- www.solventum.com
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Data from the stock’s TipRanks forecast page, read 12 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗